Abstract
Objective
The objective was to analyze completed trials assessing the effect of oral L‐arginine supplementation on clinical outcomes of patients with acute myocardial infarction (AMI).
Background
Prior trials suggest that oral L‐arginine administration improves endothelial function in patients with stable coronary artery disease (CAD). However, it is still unclear whether oral supplementation of L‐arginine has any effect on clinical outcomes in patients with unstable CAD, such as AMI.
Methods
We systematically searched PubMed, Cochrane Library, Embase, reviews, and reference lists of relevant articles. The search strategy paired the term “arginine” with the following: “coronary heart disease,” “myocardial infarction,” “cardiovascular disease,” “ischemia,” and “trial.” We conducted a meta‐analysis of randomized, placebo‐controlled L‐arginine supplementation trials that evaluated clinical outcomes in AMI patients. Two reviewers independently assessed the trials. Differences were resolved by consensus.
Results
Only 2 trials (927 participants) were included. None of the 2 studies showed a significant difference in event rate between the L‐arginine and placebo groups. In an overall pooled estimate, there was a 7% reduction in mortality in the L‐arginine treatment group (105/459, 22.9%) compared with the control group (111/455, 24.4%), which did not reach statistical significance (risk ratio [RR]: 0.93, 95% confidence interval [CI]: 0.74–1.17; P = 0.54).
Conclusion
Oral L‐arginine supplementation has no effect on the clinical outcomes of patients with AMI. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (620.0 KB).
References
- 1.World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. [Google Scholar]
- 2. Perez‐Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 2006; 40(10): 1054–1065. [DOI] [PubMed] [Google Scholar]
- 3. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840–844. [DOI] [PubMed] [Google Scholar]
- 4. Lerman A, Suwaidi JA, Velianou JL. L‐arginine: a novel therapy for coronary artery disease? Expert Opin Investig Drugs 1999; 8(11): 1785–1793. [DOI] [PubMed] [Google Scholar]
- 5. Tousoulis D, Böger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Mechanisms of disease: L‐arginine in coronary atherosclerosis—a clinical perspective. Nat Clin Pract Cardiovasc Med 2007; 4(5): 274–283. [DOI] [PubMed] [Google Scholar]
- 6. Stanislavov R, Nikolova V, Rohdewald P. Improvement of erectile function with Prelox: a randomized, double‐blind, placebo‐controlled, crossover trial. Int J Impot Res 2008; 20(2): 173–180. [DOI] [PubMed] [Google Scholar]
- 7. Miller AL. The effects of sustained‐release‐L‐arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Altern Med Rev 2006; 11(1): 23–29. [PubMed] [Google Scholar]
- 8. Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short‐term oral L‐arginine is effective when baseline flow‐mediated dilation is low: a meta‐analysis of randomized controlled trials. Am J Clin Nutr 2009; 89(1): 77–84. [DOI] [PubMed] [Google Scholar]
- 9. Pernow J, Uriuda Y, Wang Q, Li X, Nordlander R, Rydeń L. The protective effect of L‐arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J 1994; 15: 1712–1719. [DOI] [PubMed] [Google Scholar]
- 10. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses? Lancet 1998; 352: 609–613. [DOI] [PubMed] [Google Scholar]
- 11. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Contr Clin Trials 1986; 7: 177–188. [DOI] [PubMed] [Google Scholar]
- 12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003; 327: 557–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Bednarz B, Jaxa‐Chamiec T, Maciejewski P, et al. Efficacy and safety of oral l‐arginine in acute myocardial infarction. Results of the multicenter, randomized, double‐blind, placebo‐controlled ARAMI pilot trial. Kardiol Pol 2005; 62(5): 421–427. [PubMed] [Google Scholar]
- 14. Schulman SP, Becker LC, Kass DA, et al. L‐arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 2006; 295(1): 58–64. [DOI] [PubMed] [Google Scholar]